Daiichi Axes Sanofi Vaccine Pact After Pertussis Jab Manufacturing Faces Snag


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Though Daiichi Sankyo (OTC:DSNKY) and Sanofi SA (NASDAQ: SNY) came forward to help produce other pharmas' COVID-19 shots, the companies are calling it quits on their own, separate vaccine alliance in Japan. 
  • Daiichi Sankyo has decided to suspend the Squarekids combination vaccine production and a development deal for the pentavalent combination shot VN-0105 after encountering a manufacturing snag.
  • Squarekids is a tetravalent combination vaccine for the prevention of diphtheria, pertussis, tetanus, and polio.
  • In a statement, Daiichi said it would stop making and supplying Squarekids due to a problem manufacturing pertussis vaccines.
  • It's an issue the company says it's worked to resolve, but now, Daiichi has elected to stop production altogether by ending its Sanofi deal. It will stop distributing the product from March 31. 
  • Daiichi Sankyo will compensate Sanofi to the tune of 15 billion yen, with plans to record the loss in the fourth quarter of its 2020 fiscal year, which ends on March 31.
  • Price Action: SNY shares are up 0.7% at $49.45, while DSNKY shares are down 3.4% at $28.97 in the market trading session on the last check Wednesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareContractsGeneralCOVID-19 Vaccine